24 May 2013
Keywords: novartis, trileptal, gets, new, use, oked, usa
Article | 18 August 2003
The US Food and Drug Administration has granted marketing clearance for Novartis' Trileptal (oxcarbazepine) tablets and oral suspension for use
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 August 2003
23 May 2013
© 2013 thepharmaletter.com